Persons with Parkinson's disease increasingly lose their mobility over time and are eventually unable to walk. Hope for these patients rests on deep brain stimulation, also known as a brain pacemaker.

NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting ...

Researchers are investigating the mechanisms and identifying new areas of the brain that can benefit patients when stimulated ...

ATH-1105, an experimental oral therapy for ALS, was found to be safe and well tolerated in healthy adult volunteers in a ...

Using the gene scissors CRISPR and stem cells, researchers at Stockholm University and the UK Dementia Research Institute (UK ...

CRISPR-edited iPSCs uncover early mitochondrial defects shared across ALS mutations, revealing pathways that could guide future treatments.

Using the gene scissors CRISPR and stem cells, researchers have managed to identify a common denominator for different gene mutations that all cause the neurological disease ALS. The research shows ...

Using the gene scissors CRISPR and stem cells, researchers at Stockholm University and the UK Dementia Research Institute (UK ...

Discover the major causes of partial paralysis from stroke and trauma to inflammatory conditions and tumors, plus warning ...

Massachusetts General Hospital's 2025 MGH ALS Young Investigator Awards went to three scholars doing ALS research.

Two small studies published recently in Nature offer early, but important validation that stem cell treatments for Parkinson’s disease are viable. They also are a step toward a future where stem ...